Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 16, 1997JNCI Journal of the National Cancer InstituteOpen Access

Antitumor Efficacy of Adenocarcinoma Cells Engineered to Produce Interleukin 12 (IL-12) or Other Cytokines Compared With Exogenous IL-12

View Full Paper
Ask AI
Bookmark
Share

Authors

FCFederica CavalloUniversità Cattolica del Sacro CuoreMGMirella GiovarelliUniversità di CamerinoGFG ForniUniversity of Padua

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cavallo et al. (1997) studied this question.

synapsesocial.com/papers/6a2370050ff9fe11a2851da0https://doi.org/10.1093/jnci/89.14.1049
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Inhibition of Angiogenesis In Vivo by Interleukin 121995 · 728 citations
  2. 2Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts1995 · 203 citations